Economic Digest of Europe
SEE OTHER BRANDS

Fresh business and economy news from Europe

Economic Digest of Europe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Economic Digest of Europe.

Press releases published on July 23, 2025

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Reckitt Benckiser Group Plc of Class Action Lawsuit and Upcoming Deadlines - RBGLY

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Reckitt Benckiser Group Plc of Class Action Lawsuit and Upcoming Deadlines - RBGLY

NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Reckitt Benckiser Group Plc (“Reckitt” or the “Company”) (OTCMKTS: RBGLY). Such investors are advised to contact Danielle Peyton at  …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of National Grid plc - NGG

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of National Grid plc - NGG

NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of National Grid plc (“National Grid” or the “Company”) (NYSE: NGG).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CTO Realty Growth, Inc.  - CTO

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CTO Realty Growth, Inc.  - CTO

NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of CTO Realty Growth, Inc.  (“CTO” or the “Company”) (NYSE: CTO).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646 …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Jasper Therapeutics, Inc. - JSPR

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Jasper Therapeutics, Inc. - JSPR

NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Jasper Therapeutics, Inc. (“Jasper” or the “Company”) (NASDAQ: JSPR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com  …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of argenx SE - ARGX

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of argenx SE - ARGX

NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  argenx SE (“argenx” or the “Company”) (NASDAQ: ARGX).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581- …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Unicycive Therapeutics, Inc. - UNCY

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Unicycive Therapeutics, Inc. - UNCY

NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (NASDAQ: UNCY).  Such investors are advised to contact Danielle Peyton at newaction@ …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BellRing Brands, Inc. – BRBR

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BellRing Brands, Inc. – BRBR

NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of BellRing Brands, Inc. (“BellRing” or the “Company”) (NYSE: BRBR).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Altimmune, Inc. - ALT

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Altimmune, Inc. - ALT

NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Altimmune, Inc.  (“Altimmune” or the “Company”) (NASDAQ: ALT).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or …

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Vestis Corporation of Class Action Lawsuit and Upcoming Deadlines - VSTS

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Vestis Corporation of Class Action Lawsuit and Upcoming Deadlines - VSTS

NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Vestis Corporation (“Vestis” or the “Company”) (NYSE: VSTS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw. …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tesla, Inc. - TSLA

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tesla, Inc. - TSLA

NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Tesla, Inc. (“Tesla” or the “Company”) (NASDAQ: TSLA).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581- …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abacus Global Management, Inc.- ABL

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abacus Global Management, Inc.- ABL

NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL).  Such investors are advised to contact Danielle Peyton at newaction@ …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of KBR, Inc. - KBR

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of KBR, Inc. - KBR

NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of KBR, Inc.  (“KBR” or the “Company”) (NYSE: KBR).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX

NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Edgewise Therapeutics, Inc. (“Edgewise” or the “Company”) (NASDAQ: EWTX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw. …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lineage, Inc.- LINE

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lineage, Inc.- LINE

NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Lineage, Inc. (“Lineage” or the “Company”) (NASDAQ: LINE).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646- …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Groupon, Inc. - GRPN

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Groupon, Inc. - GRPN

NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Groupon, Inc. (“Groupon” or the “Company”) (NASDAQ: GRPN).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646- …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc.  - DYN

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc. - DYN

NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Dyne Therapeutics, Inc. (“Dyne” or the “Company”) (NASDAQ: DYN).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of United Natural Foods, Inc. - UNFI

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of United Natural Foods, Inc. - UNFI

NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of United Natural Foods, Inc. (“United Natural” or the “Company”) (NYSE: UNFI).  Such investors are advised to contact Danielle Peyton at newaction@ …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Designer Brands Inc. - DBI

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Designer Brands Inc. - DBI

NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Designer Brands Inc.  (“Designer Brands” or the “Company”) (NYSE: DBI).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw. …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sable Offshore Corp. - SOC

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sable Offshore Corp. - SOC

NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Sable Offshore Corp. (“Sable” or the “Company”) (NYSE: SOC).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646- …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Sciences, Inc. - GILD

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Sciences, Inc. - GILD

NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Gilead Sciences, Inc. (“Gilead” or the “Company”) (NASDAQ: GILD).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions